Stockholders' Equity, Earnings Per Share and Share Repurchases

12 Months Ended

Dec. 28, 2024

Stockholders' Equity, Earnings Per Share and Share Repurchases

Stockholders’ Equity - Common Stock and Preferred Stock

The Company has authorized 20 million shares of common stock with a par value of $0.01 per share. The Company has only one class of common stock authorized and issued. Holders of the Company’s common stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders and there are no cumulative voting rights. The Company’s common stock has no preemptive, redemption, conversion or subscription rights. The Company has generally not paid cash dividends on its common stock. Any future dividend payments would be subject to the discretion of the Company’s board of directors and contractual restrictions under the Company’s revolving credit facility and senior secured notes. The BlueLinx Holdings Inc. 2021 Long-Term Incentive Plan does not permit the payment of dividends or dividend equivalents on unvested grants that include underlying shares of the Company’s common stock.

The Company has authorized 30 million shares of preferred stock with a par value of $0.01 per share. The Company has never issued any shares of preferred stock. The Company’s board of directors is authorized to issue, at any time and from time to time, shares of preferred stock in one or more series. The shares of preferred stock in any series can have preferences with respect to the Company’s common stock and other series of preferred stock, and such other rights, restrictions or limitations with respect to voting, dividends, conversion, exchange, redemption and any other matters, as may be set forth by the Company’s board of directors.

Earnings Per Share

The Company calculates basic earnings per share by dividing net income for the period by the weighted average number of common shares outstanding for the period. For rounding purposes when calculating earnings per share, the Company’s policy is to round down to the whole cent.

Diluted earnings per share are calculated using the treasury stock method whereby net income for the period is divided by the weighted average number of common shares outstanding for the period plus the dilutive effect, if any, of shares of stock associated with unvested share-based grants. However, for performance-based share-based grants, the dilutive effect is included only for grants where the performance goals have been achieved.

The reconciliations of basic net income and diluted earnings per common share for fiscal 2024, fiscal 2023, and fiscal 2022 were as follows:


	Fiscal Year Ended
	December 28, 2024		December 30, 2023		December 31, 2022
	(amounts in thousands, except per share amounts)
Net income	$	53,116	$	48,536	$	296,176

Weighted average shares outstanding - Basic	8,531		8,987		9,328
Dilutive effect of share-based awards	41		7		70
Weighted average shares outstanding - Diluted	8,572		8,994		9,398

Basic earnings per share	$	6.22	$	5.40	$	31.75
Diluted earnings per share	$	6.19	$	5.39	$	31.51

For fiscal years 2024, 2023, and 2022, weighted-average unvested time-based restricted stock units totaling 376, 107,498, and 69,070, respectively, and weighted-average unvested performance-based restricted stock units totaling 118,938, 82,042, and 30,860, respectively, were outstanding but not included in the computation of diluted earnings per share for the respective periods. The unvested time-based restricted stock units were excluded because they were antidilutive based on their unearned compensation amounts and on the Company’s average stock price during the periods. The unvested performance-based

restricted stock units were excluded because their performance metrics had not been achieved as of the end of the respective reporting period.

Share Repurchases

2021/2022 Authorization

On August 23, 2021, the Company’s board of directors approved a stock repurchase program that authorized the Company to repurchase up to $25.0 million of its common stock. During the first quarter of fiscal 2022, the Company repurchased 81,331 shares of its common stock under this program at an average price of $79.03 per share. On May 3, 2022, the Company’s board of directors increased the share repurchase authorization to $100 million and the Company entered into an accelerated share repurchase agreement (the “ASR Agreement”) to repurchase $60 million of its common stock. Under the ASR Agreement, the Company received delivery of 801,015 shares of its common stock in fiscal 2022 at an average price of $74.90 per share. During fiscal 2023, the Company exhausted the remaining available capacity under its stock repurchase program by completing the repurchases of 404,796 shares at an average price of $82.91 through October 2023.

2023 Authorization

On October 31, 2023, the Company’s board of directors authorized a share repurchase program for $100 million. Under this share repurchase program, the Company may repurchase its common stock from time to time, without prior notice, subject to prevailing market conditions and other considerations. Repurchases may be made through a variety of methods, which may include open market purchases, privately negotiated transactions, accelerated share repurchase programs, tender offers or pursuant to a trading plan that may be adopted in accordance with the Securities and Exchange Commission Rule 10b5-1. During the fourth quarter of fiscal 2023, the Company repurchased 101,516 shares of its common stock at an average price of $84.45, including broker commissions but excluding excise taxes. During fiscal 2024, the Company repurchased 428,630 shares of its common stock at an average price of $104.90, including broker commissions but excluding excise taxes. As of December 28, 2024, a total of 530,146 shares of the Company’s commons stock have been repurchased under the 2023 authorization at an average price of $100.99, including broker commissions but excluding excise taxes. As of December 28, 2024, there remains $46.5 million repurchase capacity under this authorization.

Common stock repurchases of $45.3 million and $42.5 million for fiscal years 2024 and 2023, respectively, as indicated on the Company’s consolidated statement of stockholders’ equity include accrued excise taxes of $0.4 million and $0.3 million, respectively, that are deemed to be a cost of the share repurchases. Excise taxes levied against a current year’s share repurchases are typically paid in the following year per applicable law. On the Company’s consolidated statements of cash flow, these excise taxes are reflected in the fiscal period of payment.